4
Changes in Ownership
SpyGlass Pharma, Inc. Filed Acc 0001193125-26-045029
Director bought 165,000 shares at $16.00 ($2,640,000)
- Director acquired 3,145,619 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Nielsen Kirk G. Director | 2026-02-09 | Conversion | +1,690,230 | 1,690,230 | I: show line 1 in the form | ||
| Nielsen Kirk G. Director | 2026-02-09 | Conversion | +548,067 | 2,238,297 | I: show line 2 in the form | ||
| Nielsen Kirk G. Director | 2026-02-09 | Conversion | +548,067 | 2,786,364 | I: show line 3 in the form | ||
| Nielsen Kirk G. Director | 2026-02-09 | Conversion | +359,255 | 3,145,619 | I: show line 4 in the form | ||
| Nielsen Kirk G. Director | 2026-02-09 | Purchase | +165,000 | $16.00 | $2,640,000 | 3,310,619 | I: show line 5 in the form |
| Open-market purchases · 165,000 sh · avg $16.00 · $2,640,000 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Nielsen Kirk G. Director | 2026-02-09 | Conversion · Series B Preferred Stock | −9,689,922 | 0 | I: show line 6 in the form | |||||
| Nielsen Kirk G. Director | 2026-02-09 | Conversion · Series C-1 Preferred Stock | −3,142,015 | 0 | I: show line 7 in the form | |||||
| Nielsen Kirk G. Director | 2026-02-09 | Conversion · Series C-2 Preferred Stock | −3,142,015 | 0 | I: show line 8 in the form | |||||
| Nielsen Kirk G. Director | 2026-02-09 | Conversion · Series D Preferred Stock | −2,059,573 | 0 | I: show line 9 in the form |
Loading xslF345X05/ownership.xml…